TScan Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
TScan Therapeutics has a total shareholder equity of $150.9M and total debt of $30.0M, which brings its debt-to-equity ratio to 19.9%. Its total assets and total liabilities are $272.1M and $121.3M respectively.
Key information
19.9%
Debt to equity ratio
US$30.05m
Debt
| Interest coverage ratio | n/a |
| Cash | US$192.04m |
| Equity | US$150.87m |
| Total liabilities | US$121.28m |
| Total assets | US$272.15m |
Recent financial health updates
Is TScan Therapeutics (NASDAQ:TCRX) Using Too Much Debt?
Feb 17
Here's Why We're Watching TScan Therapeutics' (NASDAQ:TCRX) Cash Burn Situation
May 22Will TScan Therapeutics (NASDAQ:TCRX) Spend Its Cash Wisely?
Jan 17We're Keeping An Eye On TScan Therapeutics' (NASDAQ:TCRX) Cash Burn Rate
Oct 18Recent updates
Subdued Growth No Barrier To TScan Therapeutics, Inc.'s (NASDAQ:TCRX) Price
Mar 23Is TScan Therapeutics (NASDAQ:TCRX) Using Too Much Debt?
Feb 17TScan Therapeutics, Inc. (NASDAQ:TCRX) Just Reported, And Analysts Assigned A US$10.75 Price Target
Mar 11TScan Therapeutics GAAP EPS of -$0.63 beats by $0.13, revenue of $4.05M beats by $1.05M
Aug 10TScan Therapeutics appoints Debora Barton as Chief Medical Officer
Jul 07Here's Why We're Watching TScan Therapeutics' (NASDAQ:TCRX) Cash Burn Situation
May 22Will TScan Therapeutics (NASDAQ:TCRX) Spend Its Cash Wisely?
Jan 17We're Keeping An Eye On TScan Therapeutics' (NASDAQ:TCRX) Cash Burn Rate
Oct 18Financial Position Analysis
Short Term Liabilities: TCRX's short term assets ($194.2M) exceed its short term liabilities ($29.8M).
Long Term Liabilities: TCRX's short term assets ($194.2M) exceed its long term liabilities ($91.5M).
Debt to Equity History and Analysis
Debt Level: TCRX has more cash than its total debt.
Reducing Debt: Insufficient data to determine if TCRX's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TCRX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TCRX has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 33.2% each year.